DANAHER JOHN W MD
Known title: Pres. - Adtalem Med & VetCIK: 0001309445
Associated companies
Transaction History
| CVSA | ▼ Sell | Tax Withholding | 2,949 | $127K | 8/25/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 419 | $18K | 8/24/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 2,934 | $121K | 8/25/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 4,420 | $176K | 8/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.